Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Non-Current Liabilities (2016 - 2017)

Tenax Therapeutics' Total Non-Current Liabilities history spans 6 years, with the latest figure at $802474.0 for Q3 2017.

  • For Q3 2017, Total Non-Current Liabilities fell 93.69% year-over-year to $802474.0; the TTM value through Sep 2017 reached $802474.0, down 93.69%, while the annual FY2016 figure was $6.0 million, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q3 2017 was $802474.0 at Tenax Therapeutics, down from $2.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $12.9 million in Q2 2016 and bottomed at -$82.8 million in Q2 2014.
  • The 5-year median for Total Non-Current Liabilities is -$293438.0 (2016), against an average of -$6.0 million.
  • The largest annual shift saw Total Non-Current Liabilities tumbled 123.66% in 2014 before it skyrocketed 1799.17% in 2017.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $4.6 million in 2013, then tumbled by 115.66% to -$716759.0 in 2014, then surged by 1779.7% to $12.0 million in 2015, then plummeted by 50.39% to $6.0 million in 2016, then crashed by 86.57% to $802474.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Total Non-Current Liabilities are $802474.0 (Q3 2017), $2.1 million (Q2 2017), and $5.0 million (Q1 2017).